C-Type lectin-like receptors of the dectin-1 cluster: Ligands and signaling pathways

International Reviews of Immunology

Volumn 32, Issue 2, 2013, Pages 134-156

  Plato, Anthony ^a   Willment, Janet A ^a   Brown, Gordon D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

C type lectin; ITAM like; ITIM; Syk; Tri acidic

Indexed keywords

C TYPE LECTIN LIKE RECEPTOR; C TYPE LECTIN LIKE RECEPTOR 1; C TYPE LECTIN LIKE RECEPTOR 2; C TYPE LECTIN LIKE RECEPTOR 9A; CRYOPYRIN; DECTIN 1; DECTIN 2; LIGAND; MACROPHAGE ANTIGEN H; MYELOID INHIBITORY C TYPE LIKE LECTIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; RECEPTOR PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; HOMEOSTASIS; HUMAN; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIGAND BINDING; MOLECULAR RECOGNITION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN MOTIF; RECEPTOR BINDING; REVIEW;

AMINO ACID MOTIFS; ANIMALS; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS, C-TYPE; LIGANDS; SIGNAL TRANSDUCTION;

EID: 84876117810     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2013.777065     Document Type: Review

References (99)

1. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009;30:766-775.
2. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002;111:927-930. (Pubitemid 36044685)
3. Janeway CA, Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54(Pt 1):1-13. (Pubitemid 20177564)
4. Kerrigan AM, Brown GD. Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activationmotifs. Immunol Rev 2010;234:335-352.
5. Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006;6:33-43. (Pubitemid 43279751)
6. Kohchi C, Inagawa H,Nishizawa T, et al. ROS and innate immunity. Anticancer Res 2009;29:817-821.
7. Blander JM, Medzhitov R. On regulation of phagosome maturation and antigen presentation. Nat Immunol 2006;7:1029-1035. (Pubitemid 44420647)
8. Leulier F, Lemaitre B. Toll-like receptors-taking an evolutionary approach. Nat Rev Genet 2008;9:165-178.
9. Yamamoto M, Takeda K. Current views of Toll-like receptor signaling pathways. Gastroenterol Res Practice 2010;2010:240365.
10. Tarang S, Kumar S, Batra SK. Mucins and Toll-like receptors: kith and kin in infection and cancer. Cancer Lett 2012;321:110-119.
11. Pasare C,Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv ExpMed Biol 2005;560:11-18.
12. Iwasaki A,Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995. (Pubitemid 41057715)
13. Lamkanfi M, Kanneganti TD. Regulation of immune pathways by the NOD-like receptor NLRC5. Immunobiology 2012;217:13-16.
14. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011;30:16-34.
15. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801. (Pubitemid 43261452)
16. SchneiderM, Zimmermann AG, Roberts RA, et al.The innate immune sensorNLRC3 attenuates Tolllike receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NFkappaB. Nat Immunol 2012;13:823-831.
17. Rubino SJ, SelvananthamT, Girardin SE, et al. Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol 2012;24:398-404.
18. Strober W, Murray PJ, Kitani A, et al. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006;6:9-20. (Pubitemid 43279749)
19. StroberW,Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease.Mucosal Immunol 2011;4:484-495.
20. Conti BJ, Davis BK, Zhang J, et al. CATERPILLER 16.2 (CLR16.2), a novel NBD/LRR family member that negatively regulates T cell function. J Biol Chem 2005;280:18375-18385. (Pubitemid 41389086)
21. Zhao Y, Shao F. NLRC5: aNOD-like receptor proteinwithmany faces in immune regulation. Cell Res 2012;22:1099-1101.
22. Poeck H, Ruland J. SYK kinase signaling and the NLRP3 inflammasome in antifungal immunity. JMolMed (Berl) 2010;88:745-752.
23. Wen H, Ting JP, O'Neill LA. A role for the NLRP3 inflammasome in metabolic diseases-didWarburg miss inflammation? Nat Immunol 2012;13:352-357.
24. Leung DW, Basler CF, Amarasinghe GK. Molecular mechanisms of viral inhibitors of RIG-I-like receptors. TrendsMicrobiol 2012;20:139-146.
25. Satoh T, KatoH, Kumagai Y, et al. LGP2 is a positive regulator of RIG-I-andMDA5-mediated antiviral responses. Proc Natl Acad Sci USA 2010;107:1512-1517.
26. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 2005;6:981-988. (Pubitemid 41486182)
27. TakahashiK,Kawai T,KumarH, et al. Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 2006;176:4520-4524.
28. Dixit E, Boulant S, Zhang Y, et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010;141:668-681.
29. Geijtenbeek TB, van Vliet SJ, Engering A, et al. Self-and nonself-recognition by C-type lectins on dendritic cells. Ann Rev Immunol 2004;22:33-54. (Pubitemid 38680417)
30. Zelensky AN, Gready JE.TheC-type lectin-like domain superfamily.TheFEBS J 2005;272:6179-6217.
31. Sancho D, Reis e Sousa C. Signaling bymyeloidC-type lectin receptors in immunity and homeostasis. Ann Rev Immunol 2012;30:491-529.
32. Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nature Rev Immunol 2009;9:465-479.
33. Huysamen C, Brown GD.Thefungal pattern recognition receptor,Dectin-1, and the associated cluster of C-type lectin-like receptors. FEMSMicrobiol Lett 2009;290:121-128.
34. Tsang E,Giannetti AM, ShawD, et al.Molecular mechanism of the Syk activation switch. J Biol Chem 2008;283:32650-32659.
35. Lowell CA. Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk. Cold Spring Harbor Perspectives Biol 2011;3:10.1101/cshperspect.a002352.
36. Drummond RA, Saijo S, Iwakura Y, et al.Therole of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol 2011;41:276-281.
37. Sattler M, Verma S, Pride YB, et al. SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulatesmigration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL. J Biol Chem 2001;276:2451-2458.
38. Svajger U, Anderluh M, Jeras M, et al. C-type lectin DC-SIGN: an adhesion, signalling and antigenuptake molecule that guides dendritic cells in immunity. Cell Signal 2010;22:1397-1405.
39. Gringhuis SI, den Dunnen J, Litjens M, et al. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol 2009;10:1081-1088.
40. Gringhuis SI, den Dunnen J, Litjens M, et al. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007;26:605-616. (Pubitemid 46756345)
41. Takahara K, Tokieda S, Nagaoka K, et al. C-type lectin SIGNR1 enhances cellular oxidative burst response against C. albicans in cooperation with Dectin-1. Eur J Immunol 2011;41:1435-1444.
42. Kerrigan AM, Brown GD. Syk-coupled C-type lectins in immunity. Trends Immunol 32:151-156.
43. BrownGD,Gordon S.Immune recognition. A new receptor for beta-glucans.Nature 2001;413:36-37. (Pubitemid 32843478)
44. Ariizumi K, Shen GL, Shikano S, et al. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem 2000;275:20157-20167. (Pubitemid 30441627)
45. Vautier S, Drummond RA, Redelinghuys P, et al. Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infect Immun 2012;80:4216-4222.
46. Hardison SE, Brown GD. C-type lectin receptors orchestrate antifungal immunity. Nat Immunol 2012;13:817-822.
47. Rawlings DJ, Sommer K,Moreno-Garcia ME.The CARMA1 signalosomelinks the signallingmachinery of adaptive and innate immunity in lymphocytes. Nat Rev Immunol 2006;6:799-812. (Pubitemid 44631649)
48. Gringhuis SI,Wevers BA, Kaptein TM, et al. Selective C-Rel activation viaMalt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2. PLoS Pathog 2011;7:e1001259.
49. Gringhuis SI, den Dunnen J, Litjens M, et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol 2009;10:203-213.
50. Underhill DM, Rossnagle E, Lowell CA, et al. Dectin-1 activates Syk tyrosine kinase in a dynamic subset ofmacrophages for reactive oxygen production. Blood 2005;106:2543-2550. (Pubitemid 41510832)
51. Fric J, Zelante T,Wong AY, et al. NFAT control of innate immunity. Blood 2012;120:1380-1389.
52. Goodridge HS, Underhill DM. Fungal recognition by TLR2 and Dectin-1. Handb Exp Pharmacol 2008:87-109.
53. Taylor PR, Brown GD, Herre J, et al.The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specificmacrophages. J Immunol 2004;172:1157-1162. (Pubitemid 38113776)
54. Dennehy KM, Ferwerda G, Faro-Trindade I, et al. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol 2008;38: 500-506.
55. Mantegazza AR, BarrioMM,Moutel S, et al.CD63 tetraspanin slows down cellmigration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells. Blood 2004;104:1183-1190. (Pubitemid 39038041)
56. Li X, Utomo A, Cullere X, et al. The beta-glucan receptor Dectin-1 activates the integrin Mac-1 in neutrophils via Vav protein signaling to promote Candida albicans clearance. Cell Host Microbe 2011;10:603-615.
57. Sancho D, Mourao-Sa D, Joffre OP, et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest 2008;118:2098-2110. (Pubitemid 351872329)
58. Caminschi I, Proietto AI, Ahmet F, et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008;112:3264-3273.
59. Poulin LF, Salio M, Griessinger E, et al. Characterization of human DNGR-1 + BDCA3+ leukocytes as putative equivalents ofmouse CD8alpha+ dendritic cells. J ExpMed 2010;207:1261-1271.
60. Zhang JG, Czabotar PE, Policheni AN, et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 2012;36:646-657.
61. Ahrens S, Zelenay S, Sancho D, et al. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 2012;36:635-645.
62. Geijtenbeek TB. Actin' as a death signal. Immunity 2012;36:557-559.
63. Zelenay S, Keller AM, Whitney PG, et al.The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J Clin Invest 2012;122:1615-1627.
64. Huysamen C, Willment JA, Dennehy KM, et al. CLEC9A is a novel activation C-type lectinlike receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J. Biol Chem 2008;283:16693-16701.
65. Sancho D, Joffre OP, Keller AM, et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009;458:899-903.
66. ColonnaM, Samaridis J,Angman L.Molecular characterization of twonovelC-type lectin-like receptors, one of which is selectively expressed in human dendritic cells. Eur J Immunol 2000;30:697-704. (Pubitemid 30098866)
67. Suzuki-Inoue K, Fuller GL, Garcia A, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006;107:542-549. (Pubitemid 43076377)
68. Hughes CE, Sinha U, Pandey A, et al. Critical role for an acidic amino acid region in platelet signalling by the hemITAM (hemi-Immunoreceptor Tyrosine-based Activation Motif ) containing receptor CLEC-2 (C-type Lectin receptor-2). J Biol Chem 2012;288(7):5127-5135.
69. Fuller GL, Williams JA, Tomlinson MG, et al. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem 2007;282:12397-12409. (Pubitemid 47100620)
70. Watson AA, Brown J, Harlos K, et al. The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2. J Biol Chem 2007;282:3165-3172. (Pubitemid 47084318)
71. Kato Y, Kaneko MK, Kunita A, et al. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci 2008;99:54-61. (Pubitemid 350239031)
72. Suzuki-Inoue K, Kato Y, Inoue O, et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem 2007;282:25993-26001. (Pubitemid 47443800)
73. Pollitt AY,Grygielska B, Leblond B, et al. Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac. Blood 2010;115:2938-2946.
74. KerriganAM,Dennehy KM,Mourao-Sa D, et al.CLEC-2 is a phagocytic activation receptor expressed onmurine peripheral blood neutrophils. J Immunol (Baltimore,MD: 1950) 2009;182:4150-4157.
75. Hughes CE, Pollitt AY,Mori J, et al. CLEC-2 activates Syk through dimerization. Blood 115:2947-2955.
76. Christou CM, Pearce AC,Watson AA, et al. Renal cells activate the platelet receptor CLEC-2 through podoplanin. Biochem J 2008;411:133-140. (Pubitemid 351482355)
77. Pleines I, Elvers M, Strehl A, et al. Rac1 is essential for phospholipase C-gamma2 activation in platelets. Pflugers Arch 2009;457:1173-1185.
78. Mourao-Sa D, Robinson MJ, Zelenay S, et al. CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur J Immunol 2011;41:3040-3053.
79. Redelinghuys P, Brown GD. Inhibitory C-type lectin receptors in myeloid cells. Immunol Lett 2011;136:1-12.
80. Marshall AS,Willment JA, LinHH,et al. Identification and characterization of a novelhumanmyeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J Biol Chem 2004;279:14792-14802. (Pubitemid 38618868)
81. van Rhenen A, van Dongen GA, Kelder A, et al. The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood 2007;110:2659-2666. (Pubitemid 47523190)
82. Zhao X, Singh S, Pardoux C, et al. Targeting C-type lectin-likemolecule-1 for antibody-mediated immunotherapy in acutemyeloid leukemia. Haematologica 2009;95:71-78.
83. Chen CH, Floyd H, Olson NE, et al. Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cellmaturation and cytokine production. Blood 2006;107:1459-1467. (Pubitemid 43242382)
84. Han Y, Zhang M, Li N, et al. KLRL1, a novel killer cell lectin like receptor, inhibits natural killer cell cytotoxicity. Blood 2004;104:2858-2866. (Pubitemid 39434972)
85. Sattler S, Ghadially H, Reiche D, et al. Evolutionary development and expression pattern of the myeloid lectin-like receptor gene family encoded within the NK gene complex. Scand J Immunol 2010;72:309-318.
86. Hoffmann SC, Schellack C, Textor S, et al. Identification of CLEC12B, an inhibitory receptor on myeloid cells. J Biol Chem 2007;282:22370-22375. (Pubitemid 47267364)
87. Sobanov Y, Bernreiter A, Derdak S, et al. A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex. Eur J Immunol 2001;31:3493-3503. (Pubitemid 34030962)
88. Sattler S, Reiche D, Sturtzel C, et al.Thehuman C-type lectin-like receptor CLEC-1 is upregulated by TGF-beta and primarily localized in the endoplasmic membrane compartment. Scand J Immunol 2012;75:282-292.
89. Thebault P, Lhermite N, Tilly G, et al.The C-type lectin-like receptor CLEC-1, expressed by myeloid cells and endothelial cells, is up-regulated by immunoregulatory mediators and moderates T cell activation. J Immunol 2009;183:3099-3108.
90. Li Y, Duan Z, Gao D, et al. The new role of LOX-1 in hypertension induced neuronal apoptosis. Biochem Biophys Res Commun 425:735-740.
91. Shimaoka T,KumeN,Minami M, et al. LOX-1 supports adhesion of gram-positive and gram-negative bacteria. J Immunol 2001;166:5108-5114. (Pubitemid 32280724)
92. Mitra S, Goyal T, Mehta JL. Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther 2011;25:419-429.
93. Hayashida K, Kume N, Murase T, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome-A novel marker for early diagnosis. Circulation 2005;112:812-818. (Pubitemid 41170066)
94. OBrien PJ, Dameron GW, BeckML, et al. Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Animal Sci 1997;47:486-495.
95. Pant S, Deshmukh A,Mehta JL. The LOX-1 scavenger receptor and its implication in coronary artery disease. Clin Lipidol 2012;7:271-273.
96. Zhu H, Lee C, Zhang D, et al. Surface-associated GroEL facilitates the adhesion of Escherichia coli to macrophages through lectin-like oxidized low-density lipoprotein receptor-1.Microbes Infect 2012. http://dx.doi.org/10. 1016/j.micinf.2012.10.001.
97. Dunn S, Vohra RS,Murphy JE, et al.Thelectin-like oxidized low-density-lipoprotein receptor: a proinflammatory factor in vascular disease. Biochem J 2008;409:349-355. (Pubitemid 351184953)
98. Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000;101:2889-2895. (Pubitemid 30415877)
99. Li D, Mehta JL. Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res 2009;104:566-568.